CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.
September 9th 2025
For patients with relapsed/refractory mantle cell lymphoma Lunsumio plus Polivy was associated with durable responses.